COVID-19 infection
305 results
1 - 100Long-term symptoms of coronavirus infection (COVID-19)
Sudden hearing loss not linked to COVID-19 infection or vaccination
Multisystem inflammatory syndrome in children (MIS-C) with COVID-19 infection
COVID-19 research briefs: Updated age-specific mortality patterns related to SARS-CoV-2 infection.
Large increases in the risk of cardiovascular events following COVID-19 infection that required hospitalization
Concurrent COVID-19 infection does not affect the sensitivity of D-dimer for pulmonary embolism diagnosis
COVID-19 vaccine moderately effective (48%) at preventing symptomatic infection in children 5 to 11 years old
COVID-19 research briefs: Antibody testing yields variable results; population study provides rich data on infection rates
COVID-19 research briefs: Antihypertensive use not associated with an increased risk of SARS-CoV-2 infection
COVID-19 research briefs: anosmia common in SARS-CoV-2 infection, and a negative trial of hydroxychloroquine
COVID-19 research briefs: Using public transportation or socializing in food/beverage outlets increases rates of infection
COVID-19 research briefs: rapid control of outbreak in Beijing; antibodies estimate infection fatality ratio in Iceland
Booster with Pfizer mRNA vaccine significantly reduces likelihood of infection and severe illness due to COVID-19 in adults 60+
Three-dose vaccine or 2 doses + previous infection protect against severe disease from BA.1 or BA.2 COVID-19 variants
Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol‐generating procedures (AGPs) on patients without suspected or confirmed COVID‐19 infection
Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them